In the last trading session, 1.38 million shares of the Caribou Biosciences Inc (NASDAQ:CRBU) were traded, and its beta was 2.54. Most recently the company’s share price was $3.99, and it changed around $0.14 or 3.64% from the last close, which brings the market valuation of the company to $360.34M. CRBU currently trades at a discount to its 52-week high of $8.59, offering almost -115.29% off that amount. The share price’s 52-week low was $3.44, which indicates that the current value has risen by an impressive 13.78% since then. We note from Caribou Biosciences Inc’s average daily trading volume that its 3-month average coming to 1.60 million.

Caribou Biosciences Inc (NASDAQ:CRBU) trade information

Instantly CRBU has showed a green trend with a performance of 3.64% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently down -30.37% year-to-date, but still down -1.97% over the last five days. On the other hand, Caribou Biosciences Inc (NASDAQ:CRBU) is -24.00% down in the 30-day period.

Caribou Biosciences Inc (CRBU) estimates and forecasts

Caribou Biosciences Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 1.53 percent over the past six months and at a -28.26% annual growth rate that is well below the industry average of 13.30%.

Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -37.16%. Caribou Biosciences Inc earnings are expected to increase by -29.49% in 2024, but the outlook is positive 14.50% per year for the next five years.

CRBU Dividends

Caribou Biosciences Inc’s next quarterly earnings report is expected to be released in May.